As of May 2021, we offer new, more cost-effective services for single cell genome sequencing. This was made possible by the acquisition of Illumina’s NextSeq 2000 DNA sequencer, with the generous support of the Simons Foundation. Read more here.
As of May 2021, we offer new, more cost-effective services for single cell genome sequencing. This was made possible by the acquisition of Illumina’s NextSeq 2000 DNA sequencer, with the generous support of the Simons Foundation. Read more here.